IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAROSI, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.915
EU - Europa 6.949
AS - Asia 4.266
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 17
SA - Sud America 10
Totale 28.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.869
CN - Cina 2.872
UA - Ucraina 2.802
DE - Germania 1.150
IT - Italia 1.067
HK - Hong Kong 651
FI - Finlandia 588
IE - Irlanda 435
SG - Singapore 415
GB - Regno Unito 364
IN - India 215
FR - Francia 178
SE - Svezia 139
PL - Polonia 99
TR - Turchia 62
BE - Belgio 44
CA - Canada 40
RU - Federazione Russa 32
MU - Mauritius 22
EU - Europa 20
IR - Iran 20
AU - Australia 17
NL - Olanda 12
CZ - Repubblica Ceca 11
JP - Giappone 5
AE - Emirati Arabi Uniti 4
BR - Brasile 4
CH - Svizzera 4
HU - Ungheria 4
MX - Messico 4
NG - Nigeria 4
VN - Vietnam 4
ES - Italia 3
HR - Croazia 3
KR - Corea 3
RO - Romania 3
ZA - Sudafrica 3
AR - Argentina 2
BD - Bangladesh 2
ID - Indonesia 2
MY - Malesia 2
SA - Arabia Saudita 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LR - Liberia 1
MA - Marocco 1
MD - Moldavia 1
MS - Montserrat 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SO - Somalia 1
TH - Thailandia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 28.213
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.188
Fairfield 2.160
Jacksonville 2.079
Houston 1.185
Wilmington 1.143
Ashburn 1.097
Ann Arbor 1.023
Cambridge 949
Chandler 944
Nanjing 836
Princeton 807
Seattle 799
Hong Kong 650
Dublin 434
Nanchang 287
New York 258
Beijing 252
Singapore 236
Des Moines 197
Shenyang 197
Helsinki 183
Hebei 175
Changsha 159
San Diego 147
Tianjin 137
Jiaxing 130
Jinan 127
Dearborn 119
Milan 108
Warsaw 99
Kunming 93
Verona 77
Hangzhou 76
Shanghai 75
Lancaster 59
Kocaeli 56
Brescia 49
Zhengzhou 49
Lanzhou 46
Brussels 44
Ningbo 41
Boardman 37
Los Angeles 36
Taizhou 32
Toronto 32
Leawood 28
Guangzhou 27
San Francisco 27
Washington 26
Norwalk 25
Haikou 23
London 19
Pune 19
Augusta 18
Rome 18
Ardabil 16
Changchun 16
Taiyuan 15
Fuzhou 13
Auburn Hills 11
Falls Church 11
Brno 10
Monmouth Junction 10
Orange 10
San Mateo 9
Catania 8
Rende 8
Hefei 7
Melbourne 7
Redmond 7
Chicago 6
Hanover 6
Kilburn 6
Torino 6
Napoli 5
Palermo 5
Redwood City 5
Venezia 5
Dong Ket 4
Dubai 4
Folignano 4
Islington 4
Messina 4
Munich 4
Nürnberg 4
Pavia 4
Phoenix 4
Santa Clara 4
Shaoxing 4
Southwark 4
Sydney 4
Bergamo 3
Berlin 3
Brandizzo 3
Budapest 3
Calatabiano 3
Canberra 3
Cape Town 3
Chiswick 3
Florence 3
Totale 20.418
Salva come PNG Salva come JPEG
Nome #
Cos’è la Medicina Tropicale 221
Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA 203
Hepatitis C infection influence on immune recovery in HIV-positive patients on successful HAART: The role of genotype 3 156
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 152
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 152
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 142
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 136
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 135
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 133
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 131
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 130
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 121
HIV-associated asymmetric lipodystrophy syndrome 121
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment 119
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 118
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 118
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 117
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 116
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone 116
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 115
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and Human Immunodeficiency Virus. 114
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis 114
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 113
STI epidemics in the Indian Ocean Region: can the phase be assessed? 112
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 112
Accidental and transfusion malaria in Italy 111
Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution. 111
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 110
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month 109
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 109
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 108
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients. 107
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 106
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 105
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 105
Interleukin-2 therapy in patients with HIV infection 103
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 102
Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target? 102
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 102
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network 101
Epidemiological features and case-management practices of imported malaria in northern Italy 101
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. 101
Mortality for liver disease in patients with HIV infection: a cohort study 101
Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008 100
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 100
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 100
Polymorphic immune restoration syndrome after effective HAART 99
Filariasis in travelers presenting to the Geosentinel Surveillance Network 99
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 99
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 98
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 98
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 98
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 98
HIV-related liver disease: ARV drugs, coinfection, and other risk factors. 98
High prevalence of radiological vertebral fractures in HIV-infected males 98
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 98
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 97
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of Foscarnet versus Ganciclovir. 97
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 97
Malaria and HIV in adults: When the parasite runs into the virus 97
Fatal disseminated toxoplasmosis during primary HIV infection. 96
CD4+ T cell evolution and predictors of its trend before and aftertenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load 96
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 96
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006 95
Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. 95
Risk factors for myocardial infarction in HIV positive patients 95
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects 95
Baggage Malaria in Italy: Cryptic Malaria explained? 94
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial 94
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006). 94
Adherence to surgical site infection guidelines in Italian cardiac surgery units. 94
Towards HCV extinction with modern HCV treatment? “Yes we can!” 94
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. 93
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. 93
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis 93
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 93
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy). 93
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 93
Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. 92
Outcome and predictive factors of mortality in hospitalized HIV-patients in Burkina Faso 92
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina 92
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 92
Analysis of current guidelines for intra-abdominal infections 92
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial 92
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 92
Anti-viral potency of HAART regimens and clinical success are not strictly coupled in real life conditions. Evidence from the MASTER-1 Study 91
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 91
Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin 91
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 91
Clinical presentation and outcome of hepatocellular carcinoma in HIV infected patients. 90
Class of antiretroviral drugs and the risk of myocardial infarction. 90
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 90
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort 89
Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma 89
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 89
I data-base clinici e la sorveglianza degli eventi avversi: il progetto MASTER 88
Gastrointestinal Infection Among International Travelers Globally 88
Worldwide epidemiology and risk for International Travelers 88
Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. 88
Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound 87
Totale 10.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.131 0 186 196 966 341 833 629 818 431 1.086 139 506
2020/20214.995 53 604 283 742 137 609 118 590 876 339 529 115
2021/20222.828 125 538 11 185 31 170 94 190 168 433 282 601
2022/20232.769 457 24 31 232 268 820 3 272 424 25 86 127
2023/20242.154 138 68 128 149 82 370 57 53 663 23 17 406
2024/202542 26 16 0 0 0 0 0 0 0 0 0 0
Totale 28.621